5-AMINO-1MQ/SLU-PP-332 — Research
Compound Combo
Dosage: 20MG/10MG
Format: Dual research compound formulation
Intended Use: Laboratory research use only
5-AMINO-1MQ/SLU-PP-332 combines two complementary metabolic research compounds
into one streamlined formulation. 5-Amino-1MQ is studied as an NNMT inhibitor involved
in nicotinamide metabolism, methylation balance, and NAD
⁺-related cellular energy
pathways. SLU-PP-332 is studied as an ERRα agonist associated with mitochondrial
biogenesis, oxidative metabolism, fatty-acid oxidation, and endurance-like energy signaling
models.
Together, these compounds provide a research-focused pairing for studying metabolic
regulation from two angles: 5-Amino-1MQ supports enzyme-level investigation of
nicotinamide and methylation pathways, while SLU-PP-332 supports transcriptional
level investigation of mitochondrial oxidative programming. This makes the
combination useful for laboratory models exploring how metabolic substrate handling,
methyl donor balance, NAD
⁺-linked signaling, and mitochondrial energy pathways may
interact.
Why This Combo Is Synergistic
The research synergy comes from the compounds’ complementary mechanisms. 5
Amino-1MQ is used to study NNMT-related metabolic and methylation control, while SLU
PP-332 is used to study ERRα-driven mitochondrial gene activation. Run together in
controlled laboratory settings, the combination may help researchers evaluate how
upstream metabolic regulation interacts with downstream mitochondrial energy
programming.
Research Use Only: 5-AMINO-1MQ/SLU-PP-332 is intended strictly for laboratory
research use only. It is not intended for human consumption, veterinary use, clinical use,
diagnostic use, therapeutic application, food or supplement manufacturing, or cosmetic
use. Any discussion of mechanism or synergy applies exclusively to non-clinical
laboratory research contexts
